Brett Greenky, MD
Adult Reconstructive Orthopaedic Surgery · Fayetteville, NYNPI 1750346060
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,411 of the $12,349 with a category attached, or 60.0%. 20 manufacturers reported payments, led by Stryker at 41.8% of the total. Reporting peaked in 2019 at $4,906 and has fallen 90.0% since, to $492 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NY, where the typical reported total is $11,547.
Across 171 payments — averaging $72.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$5K
- Smith+Nephew$3K
- Limacorporate S.p.a.$2K
- Prodigy Surgical Distribution, Inc.$1K
- Zimmer Biomet$471
- Johnson & Johnson$287
- plus $1K from 14 others
Across 84 payments — averaging $2968.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$145K
- Smith+Nephew$46K
- Limacorporate S.p.a.$41K
- Lima USA, Inc.$12K
- Medical Device Business Services, Inc.$5K
What the payments were for
- Consulting fees$2,00016%
- Travel & lodging$1,85615%
- Food & beverage$7,41160%
- Education$1,0829%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 90 | $5,160 |
| Smith+Nephew | 42 | $2,570 |
| Limacorporate S.p.a. | 2 | $1,692 |
| Prodigy Surgical Distribution, Inc. | 1 | $1,082 |
| Zimmer Biomet | 6 | $471 |
| Johnson & Johnson(2 entities) | 6 | $287 |
| Encore Medical, LP | 2 | $274 |
| Lima USA, Inc. | 2 | $227 |
| Total Joint Orthopedics, Inc. | 1 | $148 |
| Avanos Medical | 3 | $130 |
| Medical Device Business Services, Inc. | 1 | $100 |
| Pacira Pharmaceuticals Incorporated | 2 | $35 |
| Heraeus Medical, LLC. | 6 | $32 |
| Trilliant Surgical LLC. | 1 | $31 |
| Bioventus LLC | 1 | $29 |
| Vericel Corporation | 1 | $24 |
| Acelrx Pharmaceuticals, Inc. | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Vertex | 1 | $14 |
| Conformis, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,411
- Physica$1,727
- TRIATHLON$944
- TRIGEN InterTAN$384
- Legion$243
- EVOS$239
- EMPHASYS$201
- Product Portfolio$192
- Anthology$148
- Journey II CR$148
- R3$148
- REAL INTELLIGENCE$146
- RI.HIP NAVIGATION$146
- TRIGEN Meta-Nail$135
- DJO SURGICAL$132
- Persona$129
- Journey II$128
- Tandem$128
- NA$123
- TFN-Advance$119
How this compares
$12,349 in reported general payments places this provider in the 50th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.
See all adult reconstructive orthopaedic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 21 | $10,120 |
| Celecoxib | 247 | $2,958 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 233 | $1,888 |
| Naloxone Hcl | 14 | $1,101 |
| Ketorolac Tromethamine | 107 | $940 |
| Meloxicam | 365 | $865 |
| Pregabalin | 14 | $326 |
| Cyclobenzaprine Hcl | 110 | $313 |
| Amoxicillin | 252 | $229 |
| Gabapentin | 55 | $189 |
| Oxycodone Hcl | 11 | $81 |
| Azithromycin | 34 | $49 |
| Tramadol Hcl | 29 | $39 |
| Clindamycin Hcl | 11 | $5 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $287 | $10,12021 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.
Other adult reconstructive orthopaedic surgery in Fayetteville
- Seth JerabekNew York$7.1M
- Jose RodriguezNew York$3.4M
- Friedrich BoettnerNew York$2.9M
- Jonathan VigdorchikNew York$2.3M
- William LongNew York$1.5M
- Peter SculcoNew York$1.5M
- Roshan ShahNew York$1.3M
- Herbert CooperNew York$1.3M
- Matthew AustinNew York$986K
- Patrick MeereNew York$191K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.